Mirae Asset Global Investments Co., Ltd.
Position in LFCR — Lifecore Biomedical, Inc. \De\
CIK 1569395
SEOUL, M5
Position in LFCR
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$8,809
+$1,541 QoQ
Shares Held
1,678
-14.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 14 holders
Holding Since
Sep 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LFCR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Mirae Asset Global Investments Co., Ltd. holds $20,006,890 across 33 Drug Manufacturers - Specialty & Generic names. LFCR ranks #33 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
108,368 | $7,787,323 | |
| 2 | VTRS |
Viatris Inc
|
305,332 | $4,848,671 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
4,119 | $2,231,797 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
9,700 | $1,634,837 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
23,364 | $574,988 | |
| 6 | ALKS |
Alkermes plc.
|
7,454 | $390,552 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
5,982 | $382,548 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
8,947 | $303,124 |
All Filings in LFCR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,809 | 1,678 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $7,268 | 1,954 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $14,895 | 1,821 | Shares | Sole | 2026-01-26 | |
| 2024-03-31 | $57,666 | 10,860 | Shares | Defined | 2024-05-01 | |
| 2023-03-31 | $41,050 | 10,860 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $70,372 | 10,860 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $96,545 | 10,860 | Shares | Defined | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||